Cureline Group is a global translational research CRO providing comprehensive services for human biospecimen (HBS) biobanking and laboratory analyses. We have designed and implemented biobanking protocols since 2003; exceled in global preclinical regulatory affairs and clinical network management (over a hundred validated clinical partners in 18 countries); conducted precision medicine projects in all major therapeutic areas and implemented novel protocols in HBS laboratory processing, histopathology and analysis of molecular analytes. Cureline team maintains a central biorepository in the San Francisco Bay area (CA, USA), delivers comprehensive pathology report and assures a full logistics support. Working with over 600 satisfied clients, we have successfully passed inspections by global CROs, pharma and biotech customers; participated in creating the ISBER Best Practices and currently a part of the international consortia on decoding the human cancer genome (TCGA) and proteome (CPTAC) lead by the National Cancer Institute (NIH, USA).
150 North Hill Drive, Suite 24, Brisbane, CA 94005
Phone: +1 415 468 6400 | Fax: +1 415 468 2248 | Email: